2012

  • Kapetral® (Capecitabine) was registered successfully in Cyprus.
  • Remedica launches Quetra® (an anti-epileptic product containing Levetiracetam as the active ingredient).
  • An ambitious program of product development was initiated that includes both block-busters as well as products for more targeted therapies.
  • Late in the year, Remedica’s new oncology factory (Building No. 10) successfully passed a GMP inspection from the Cyprus Health Authorities.